DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,328,638 | -62.4% | 986,711 | +0.3% | 0.00% | – |
| Q2 2023 | $6,194,627 | -16.3% | 983,274 | -23.4% | 0.00% | – |
| Q1 2023 | $7,403,158 | -53.8% | 1,283,043 | -17.8% | 0.00% | – |
| Q4 2022 | $16,023,042 | -38.2% | 1,561,700 | +0.6% | 0.00% | -100.0% |
| Q3 2022 | $25,946,000 | +44.8% | 1,551,750 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $17,920,000 | -40.8% | 1,280,044 | -31.7% | 0.00% | 0.0% |
| Q1 2022 | $30,263,000 | -24.4% | 1,873,893 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $40,047,000 | +150.5% | 1,870,502 | +71.9% | 0.00% | – |
| Q3 2021 | $15,986,000 | -33.4% | 1,088,201 | -9.8% | 0.00% | -100.0% |
| Q2 2021 | $23,986,000 | +541.7% | 1,205,966 | +864.8% | 0.00% | – |
| Q1 2021 | $3,738,000 | – | 124,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,626,476 | $78,771,000 | 38.55% |
| Logos Global Management LP | 2,797,501 | $39,165,000 | 7.18% |
| Cormorant Asset Management, LP | 5,500,000 | $77,000,000 | 5.82% |
| Ghost Tree Capital, LLC | 275,000 | $3,850,000 | 2.00% |
| EcoR1 Capital, LLC | 2,634,178 | $36,878,000 | 1.27% |
| RA Capital Management | 2,186,636 | $30,613,000 | 0.82% |
| Vivo Capital, LLC | 476,589 | $6,672,000 | 0.67% |
| Avoro Capital Advisors LLC | 2,222,222 | $31,111,000 | 0.62% |
| Artal Group S.A. | 400,000 | $5,600,000 | 0.30% |
| Rock Springs Capital Management LP | 460,391 | $6,445,000 | 0.19% |